PUBLICATIONS - New from Theta Reports - Antisense Therapeutics: The Emerging World Market
This article was originally published in Clinica
Executive Summary
Since approval of the first antisense drug, Vitravene, in 1998, the pharmaceutical healthcare industry has anxiously awaited the next antisense product to reach the market. This has yet to happen, and the day still appears to be fairly far off.